Browse > Article
http://dx.doi.org/10.4040/jkan.2014.44.5.542

Incidence and Factors Influencing Oral Mucositis in Patients with Hematopoietic Stem Cell Transplantation  

Jo, Kwan Suk (Graduate School, The Catholic University of Korea)
Kim, Nam Cho (College of Nursing, The Catholic University of Korea)
Publication Information
Journal of Korean Academy of Nursing / v.44, no.5, 2014 , pp. 542-551 More about this Journal
Abstract
Purpose: This study was done to examine the incidence of oral mucositis in hematopoietic stem cell transplantation patients and to identify factors influencing oral mucositis and patient outcomes according to severity. Methods: In this retrospective study, data were collected from electronic medical records of 222 patients who had received hematopoietic stem cell transplantation. Oral mucositis was evaluated using WHO's assessment scale. Data were analyzed using Chi-square test, Fisher exact test, Spearman's correlation, Ordinal logistic regression, ANOVA and Kruskal-Wallis test. Results: A total of 69.8% of the patients evaluated developed oral mucositis (grade II and over). As a results of ordinal regression, factors influencing oral mucositis severity were found to be diagnosis, type of transplantation, oxygen inhalation and the number of antiemetics administration before transplantation. The severity of oral mucositis was found to increase the days of hospitalization, days of TPN administration, days of using antibiotics and the number and dosage of analgesics. Conclusion: The results would help predict severity of oral mucositis in hematopoietic stem cell transplantation patients and suggest that provision of appropriate nursing assessment and oral care would improve patient outcomes.
Keywords
Hematopoietic stem cells; Transplantation; Mucositis;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, et al. Emerging evidence on the pathobiology of mucositis. Supportive Care in Cancer. 2013;21(11):3233-3241. http://dx.doi.org/10.1007/s00520-013-1900-x   DOI
2 Niscola P, Romani C, Cupelli L, Scaramucci L, Tendas A, Dentamaro T, et al. Mucositis in patients with hematologic malignancies: An overview. Haematologica. 2007;92(2):222-231.   DOI
3 Larsen J, Nordstrom G, Ljungman P, Gardulf A. Symptom occurrence, symptom intensity, and symptom distress in patients undergoing highdose chemotherapy with stem-cell transplantation. Cancer Nursing. 2004;27(1):55-64.   DOI
4 Hernandez-Fernandez A, Onate-Sanchez RE, Cabrerizo-Merino MC, de Arriba-de la-Fuente F, Heras-Fernando I, Vicente-Garcia V. Influence of oral health on mucositis in patients undergoing hematopoietic progenitor cell transplantation (HPCT). Medicina Oral, Patologia Oral y Cirugia Bucal. 2012;17(1):e94-e101.
5 Ohbayashi Y, Imataki O, Ohnishi H, Iwasaki A, Ogawa T, Inagaki N, et al. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 2008;87(10):837-845. http://dx.doi.org/10.1007/s00277-008-0508-6   DOI
6 Cheng KK, Lee V, Li CH, Goggins W, Thompson DR, Yuen HL, et al. Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncology. 2011;47(3):153-162. http://dx.doi.org/10.1016/j.oraloncology.2010.11.019   DOI
7 Park MH, Park JS. Difference of oral mucositis in hospitalized cancer patients receiving chemotherapy. Asian Oncology Nursing. 2013;13(2):76-84. http://dx.doi.org/10.5388/aon.2013.13.2.76   DOI
8 Son YJ, Shin YJ, Cho MY, Kim SH, Park OS, Han SY, et al. The development of an oral care protocol for cancer patients receiving chemotherapy and its effects. Journal of Korean Clinical Nursing Research. 2011;17(1):113-122.
9 Song CE, So HS, Ju D, Kim EJ. Randomized controlled trial for preventing stomatitis and discomfort among acute leukemic patients. Journal of Korean Oncology Nursing. 2011;11(1):33-40. http://dx.doi.org/10.5388/jkon.2011.11.1.33   DOI
10 Choi SE, Kim HS. Sodium bicarbonate solution versus chlorhexidine mouthwash in oral care of acute leukemia patients undergoing induction chemotherapy: A randomized controlled trial. Asian Nursing Research. 2012;6(2):60-66.   DOI
11 Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. Journal of Clinical Oncology. 2001;19(8):2201-2205.   DOI
12 Niscola P. Mucositis in malignant hematology. Expert Review of Hematology. 2010;3(1):57-65. http://dx.doi.org/10.1586/ehm.09.71   DOI
13 Cheng KK. Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer. European Journal of Cancer Care. 2008;17(3):306-311. http://dx.doi.org/10.1111/j.1365-2354.2007.00843.x
14 Vagliano L, Feraut C, Gobetto G, Trunfio A, Errico A, Campani V, et al. Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT-results of a multicentre study. Bone Marrow Transplantation. 2011;46(5):727-732. http://dx.doi.org/10.1038/bmt.2010.184   DOI
15 Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions. Oral Oncology. 2003;39(2):91-100.   DOI   ScienceOn
16 Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R, et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. British Journal of Haematology. 2000;110(2):292-299.   DOI   ScienceOn
17 Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dental Clinics of North America. 2008;52(1):61-77. http://dx.doi.org/10.1016/j.cden.2007.10.002   DOI
18 Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. Journal of Clinical Oncology. 2004;22(7):1268-1275. http://dx.doi.org/10.1200/jco.2004.05.147   DOI   ScienceOn
19 Bolwell BJ, Kalaycio M, Sobecks R, Andresen S, Kuczkowski E, Bernhard L, et al. A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation. Bone Marrow Transplantation. 2002;30(9):587-591. http://dx.doi.org/10.1038/sj.bmt.1703694   DOI
20 Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100(9 Suppl):1995-2025. http://dx.doi.org/10.1002/cncr.20162   DOI   ScienceOn
21 Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Supportive Care in Cancer. 2007;15(5):491-496. http://dx.doi.org/10.1007/s00520-006-0176-9   DOI
22 Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Supportive Care in Cancer. 2000;8(1):33-39.
23 Eilers J, Million R. Clinical update: Prevention and management of oral mucositis in patients with cancer. Seminars in Oncology Nursing. 2011;27(4):e1-e16. http://dx.doi.org/10.1016/j.soncn.2011.08.001
24 Sonis ST. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncology. 2009;45(12):1015-1020. http://dx.doi.org/10.1016/j.oraloncology.2009.08.006   DOI   ScienceOn
25 Gabriel DA, Shea T, Olajida O, Serody JS, Comeau T. The effect of oral mucositis on morbidity and mortality in bone marrow transplant. Seminars in Oncology. 2003;30(6 Suppl 18):76-83.
26 Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD, et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Supportive Care in Cancer. 2013;21(11):3191-3207. http://dx.doi.org/10.1007/s00520-013-1871-y   DOI
27 Kashiwazaki H, Matsushita T, Sugita J, Shigematsu A, Kasashi K, Yamazaki Y, et al. A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens. Supportive Care in Cancer. 2012;20(5):933-939. http://dx.doi.org/10.1007/s00520-011-1164-2   DOI
28 Eilers J. Nursing interventions and supportive care for the prevention and treatment of oral mucositis associated with cancer treatment. Oncology Nursing Forum. 2004;31(4 Suppl):13-23. http://dx.doi.org/10.1188/04.onf.s4.13-23
29 Vokurka S, Bystricka E, Scudlova J, Mazur E, Visokaiova M, Vasilieva E, et al. The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation. European Journal of Oncology Nursing. 2011;15(5):508-512. http://dx.doi.org/10.1016/j.ejon.2011.01.006   DOI
30 Strobel ES, Bauchmuller K, Ihorst G, Engelhardt M. Frequency, severity and risk factors for oral mucositis after BEAM conditioning and autologous peripheral blood stem cell transplantation: A single center analysis and review of the literature. Leukemia and Lymphoma. 2007;48(11):2255-2260. http://dx.doi.org/10.1080/10428190701636492   DOI